pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. billion in 2022, and there has been speculation that the return rate could rise into the 30%-plus range in future. billion in 2021 to £1.8

Pharma 70

Pharma Government Manufacturing Competition 70

Pharma Pathway

SEPTEMBER 23, 2022

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance (Injectable) On 25th Sept’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 25th Sept’ 2022. Job Description.

Pharmaceutical 80

Pharmaceutical Competition Manufacturing Marketing 80

Clarivate

JANUARY 23, 2024

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g.,

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. billion in 2022. of AbbVie’s $51.8 billion in revenue to a whopping 67.2%

Pharma 52

Pharma Biopharma Medicine Competition 52

European Pharmaceutical Review

OCTOBER 5, 2022

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 82

Pharma Training Networking Doctors 82

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 101

Pharma Food and Drug Administration Recruitment Pharmacology 101

Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.

Media 52

Media Pharma Competition Marketing 52

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 109

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 109

PM360

JUNE 26, 2023

In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. Access to Medicine Index 2022”: link Firstly, entering new markets and increasing sales should boost revenue. References: 1.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023? from 2022 to 2030, the pharma industry will reach USD 9,241.34 billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! August 23, 2022. The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? dstansberry@costellocreativegroup.com.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

PharmExec

MARCH 10, 2024

Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.¬

Competition 40

Competition Pharma Sales Marketing 40

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 93

Medicine Healthcare Healthcare Pharma 93

PharmaKinnex

APRIL 18, 2022

Success Guidelines For Pharma Contract Inside Sales Forces April 18, 2022. The benefits of which provide pharma companies with flexibility and scalability. It cultivates healthy competition and allows each team member to motivate and empower each other. Inside Sales vs Outside Sales, What is the Difference?

Sales 52

Sales Pharma Physicians Electronics 52

PM360

JULY 26, 2023

Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important first order concerns: identifying products to be negotiated by the Centers for Medicare & Medicaid Services (CMS) and assessing the direct impact on prices.

Manufacturing 98

Manufacturing Pharma Competition Distribution 98

Celeritas

NOVEMBER 7, 2022

The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. The post The Value of Precision Livestock Farming (PLF) in 2022 appeared first on Celeritas | Digital Consulting. Effort Expectancy. This regards the perceived complexity involved in the operation of the system.

Networking 52

Networking Pharmaceutical products Management Transportation 52

European Pharmaceutical Review

NOVEMBER 16, 2023

With procurement practices across Europe having a strong price focus, over time, this could impact the “sustainability of biosimilars and decrease competition, as well as reducing supply reliability”, the report acknowledged. “As Act4Biosimilars is supported by its founding sponsor, Sandoz.

Marketing 87

Marketing Education Competition Consulting 87

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Competition 83

Competition Pharma Sales Medicine 83

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Read on to for insights from our analysts on: Global highlights from ESMO 2022. Key ESMO 2022 highlights from Mainland China. Seven global highlights from ESMO 2022.

Marketing 52

Marketing Safety Patients Competition 52

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

Pharmaceutical Technology

DECEMBER 20, 2022

trillion in Q2 2022 to $3.14 trillion in Q3, according to GlobalData’s Pharma Intelligence Center Companies Database. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. and 10%, respectively. GSK and Sanofi’s share prices dropped sharply by 46.4%

Biopharma 52

Biopharma Marketing Competition Sales 52

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Biopharma 78

Biopharma Government Training Education 78

European Pharmaceutical Review

FEBRUARY 27, 2023

Due to more biopharmaceutics classification system (BCS) II and BCS IV molecules being evaluated in early development, a market report has signalled that the bioavailability enhancement market will grow at a steady rate between 2022 to 2035.

Marketing 79

Marketing Distribution Pharmaceutical Competition 79

pharmaphorum

AUGUST 4, 2022

The deal comes as Amgen has been under pressure from competition to its big-selling arthritis therapy Enbrel (etanercept) and blood cell booster Epogen (epoetin alfa), and a patent expiry for psoriasis blockbuster Otezla (apremilast) in 2028. Amgen said it expects the deal to close in the fourth quarter of 2022.

Side effects 86

Side effects Pharma Sales Competition 86

Star OUTiCO

NOVEMBER 30, 2022

January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Some larger pharma clients are really going above and beyond to try and dangle that golden carrot Sarah Whitby, Pharma Outsourcing Lead.

Recruitment 98

Recruitment Pharma Leads Competition 98

pharmaphorum

JANUARY 4, 2023

In an update on the litigation posted this morning, Astellas confirmed that the Court of Appeals for the Federal Circuit (CAFC) had upheld a lower court ruling that Hospira’s generic does not infringe any of the patents that are protecting Lexiscan (regadenoson injection) from competition.

Pharmacology 57

Pharmacology Pharma Marketing Competition 57

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

European Pharmaceutical Review

JULY 18, 2022

The deal is expected to close by the end of 2022, subject to approval by the relevant competition authorities. We are committed to facilitating access to treatment for even more patients in need,” commented Gabriel Baertschi, CEO of Grünenthal.

Medicine 78

Medicine Physicians Competition Patients 78

Pharmaceutical Technology

MAY 16, 2023

trillion in Q4 2022 to $3.49 trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. According to GlobalData’s drugs database pharma intelligence centre, Wegovy is expected to generate an analyst consensus global forecast sales of $9.4 This resulted in a 3.4% million by 2029.

Marketing 52

Marketing Sales Pharma Leads 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

pharmaphorum

JANUARY 27, 2023

While global macroeconomic uncertainty continues to impact financing, the pharma industry has focused on UK biotechs to strengthen product pipelines. Both sides of the Atlantic are witnessing depressed share prices, yet there is a ray of hope: for venture capital investment in the sector, 2022 was the third-best year recorded, with £1.2

Pharma 52

Pharma Manufacturing Biopharma Medicine 52

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 86

Media Healthcare Healthcare Education 86

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form. In December, the ABPI warned that clawback – totalling almost £3.3

Government 67

Government Medicine Consulting Management 67

pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. billion in the first half of 2022. The US patent (No.

Marketing 57

Marketing Sales Competition FDA 57

PharmaKinnex

MAY 20, 2022

How to Get Started with Contract Pharmaceutical Inside Sales Companies May 20, 2022. One way to ensure pharma sales success is tapping whitespace and hard-to-reach areas within covered territories that field sales reps often cannot reach due to geographical constraints and access restrictions. When that happens everyone wins.

Sales 52

Sales Pharmaceutical Pharma Marketing 52

pharmaphorum

AUGUST 5, 2022

In Q1 2022, public markets slowed with biotech performance, dropping almost 20%, whilst the capital raised decreased by approximately 85%. Collaboration across the industry is needed now more than ever before across this complex ecosystem – not least because it’s becoming a competitive landscape. March 2022. [2] April 2022. [3]

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

PM360

JUNE 16, 2023

It’s more challenging than ever to be a pharma marketer. healthcare professionals (HCPs) agree that pharma marketing provides a personalized and relevant experience (Figure 1). Pharma marketers need to understand the individual HCP. In 2022, drugmakers’ $5.8 Rapid changes in the market resulting from COVID-19.

Marketing 59

Marketing Sales Healthcare Healthcare 59